N/A
N=15
Evaluation of Extended Wear Technology
Hearing Loss
Bottom Line
View on ClinicalTrials.gov: NCT04882800 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Dec 2022
Primary outcome: Primary: Subjective Questionnaire of Comfort — 0; 0 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lyric extended wear hearing aid device A (Device); Lyric extended wear hearing aid with fitting modification device B (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Sonova AG
- Primary completion
- May 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjective Questionnaire of Comfort |
0; 0 | — |
| PRIMARY Subjective Ratings of Occlusion With Both Devices |
0; 0 | — |
Summary
Evaluating the efficacy and effectiveness of an advancement in the fitting characteristics of extended wear technology with the commercially available device as a comparator.
Eligibility Criteria
Inclusion Criteria
- Mild, Moderate and Moderate Severe Hearing loss
- Previous extended wear technology users who rejected or cancelled trials due to discomfort, feedback, migration, or poor sound quality due to fit issues
Exclusion Criteria
- Participants who can only wear a size XXS (extra-extra small) extended wear device
- asymmetrical hearing loss
- other diagnosis that may cause hearing fluctuation
- inability to tolerate physical fit of Lyric devices
- inability to be seen for four lab visits
Data sourced from ClinicalTrials.gov (NCT04882800). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.